These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30950334)

  • 1. Leishmaniasis and Chagas Disease - Neglected Tropical Diseases: Treatment Updates.
    Sangenito LS; da Silva Santos V; d'Avila-Levy CM; Branquinha MH; Souza Dos Santos AL; de Oliveira SSC
    Curr Top Med Chem; 2019; 19(3):174-177. PubMed ID: 30950334
    [No Abstract]   [Full Text] [Related]  

  • 2. Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review.
    Santos SS; de Araújo RV; Giarolla J; Seoud OE; Ferreira EI
    Int J Antimicrob Agents; 2020 Apr; 55(4):105906. PubMed ID: 31987883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
    Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease.
    Cardona-G W; Yepes AF; Herrera-R A
    Curr Med Chem; 2018; 25(30):3637-3679. PubMed ID: 29521209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Triazole-based Molecules for the Treatment of Neglected Diseases.
    Mantoani SP; de Andrade P; Chierrito TPC; Figueredo AS; Carvalho I
    Curr Med Chem; 2019; 26(23):4403-4434. PubMed ID: 28748757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmanicidal and Trypanocidal Activity of Metal Complexes with 1,2,4-Triazolo[1,5-a]pyrimidines: Insights on their Therapeutic Potential against Leishmaniasis and Chagas Disease.
    Salas JM; Caballero AB; Esteban-Parra GM; Méndez-Arriaga JM
    Curr Med Chem; 2017; 24(25):2796-2806. PubMed ID: 28521698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
    Bilbe G
    Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
    [No Abstract]   [Full Text] [Related]  

  • 9. Initiative launched to develop drugs for neglected diseases.
    Frankish H
    Lancet; 2003 Jul; 362(9378):135. PubMed ID: 12870480
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.
    Alcântara LM; Ferreira TCS; Gadelha FR; Miguel DC
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):430-439. PubMed ID: 30293058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miltefosine (Impavido) for leishmaniasis.
    Med Lett Drugs Ther; 2014 Sep; 56(1451):89-90. PubMed ID: 25211304
    [No Abstract]   [Full Text] [Related]  

  • 12. Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue.
    Boniface PK; Ferreira EI
    Phytother Res; 2019 Oct; 33(10):2473-2517. PubMed ID: 31441148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiprotozoal compounds: state of the art and new developments.
    Astelbauer F; Walochnik J
    Int J Antimicrob Agents; 2011 Aug; 38(2):118-24. PubMed ID: 21549569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
    Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
    Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Practical Green Synthesis and Biological Evaluation of Benzimidazoles Against Two Neglected Tropical Diseases: Chagas and Leishmaniasis.
    Bandyopadhyay D; Samano S; Villalobos-Rocha JC; Sanchez-Torres LE; Nogueda-Torres B; Rivera G; Banik BK
    Curr Med Chem; 2017; 24(41):4714-4725. PubMed ID: 23317160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug design for neglected disease in Brazil.
    Giarolla J; Ferreira EI
    Mini Rev Med Chem; 2015; 15(3):220-42. PubMed ID: 25769971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-leishmanial drug discovery: rising to the challenges of a highly neglected disease.
    Sharlow ER; Grögl M; Johnson J; Lazo JS
    Mol Interv; 2010 Apr; 10(2):72-5. PubMed ID: 20368366
    [No Abstract]   [Full Text] [Related]  

  • 18. The chemotherapy of protozoal infections of man.
    Steck EA
    J Protozool; 1981 Feb; 28(1):10-6. PubMed ID: 6788942
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
    Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
    PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progresses in the field of drug design to combat tropical protozoan parasitic diseases.
    Liñares GE; Ravaschino EL; Rodriguez JB
    Curr Med Chem; 2006; 13(3):335-60. PubMed ID: 16475941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.